LEO Pharma GmbH
DEM1114.HRB11088
Firmensitz
Siemensstr. 5 b
63263 Neu-Isenburg
Hessen
Deutschland
Kontakt
Geschäftsführung
Kim Abbenhaus
Managing Director
Seit 10. Oktober 2024
Franz Peter KesselerEhemalig
Managing Director
9. August 2010 – 17. Juni 2022
Franz Peter KesselerEhemalig
Managing Director
21. Juni 2022 – 12. Juli 2022
Marc Anton HeimEhemalig
Managing Director
17. Juni 2022 – 13. November 2024
Finanzen
| Jahr | Umsatz | Gewinn | Bilanzsumme | Eigenkapitalquote |
|---|---|---|---|---|
| 2024 | 156.240.828 € | 3.495.028 € | 51.943.574 € | 56.3% |
| 2023 | 133.716.953 € | 3.297.906 € | 48.128.230 € | 53.5% |
| 2022 | 135.244.657 € | 3.017.520 € | 73.068.065 € | 30.7% |
| 2021 | 128.922.582 € | 3.582.376 € | 79.624.153 € | 24.4% |
| 2020 | 97.775.433 € | 1.693.085 € | 50.124.620 € | 31.6% |
Branche
NACE 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenWZ 21.20.0Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Rohdaten
{
"id": "6a2cb6ef-a872-4d54-bd7c-71cd22f28629",
"euId": "DEM1114.HRB11088",
"name": "LEO Pharma GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2002-10-23T00:00:00",
"vatId": "DE152387367",
"hq": {
"line2": null,
"street": "Siemensstr. 5 b",
"city": "Neu-Isenburg",
"zipCode": "63263",
"state": "HE",
"country": "DE",
"latitude": 50.04797,
"longitude": 8.6764678
},
"contactData": {
"emails": [
"info@leo-pharma.de"
],
"phones": [
"+49 61022010"
],
"websites": [
"https://leo-pharma.de/"
],
"faxes": [
"+49 6102201200"
]
},
"managers": [
{
"name": "Franz Peter Kesseler",
"position": "Managing Director",
"startDate": "2010-08-09T00:00:00",
"endDate": "2022-06-17T00:00:00"
},
{
"name": "Franz Peter Kesseler",
"position": "Managing Director",
"startDate": "2022-06-21T00:00:00",
"endDate": "2022-07-12T00:00:00"
},
{
"name": "Kim Abbenhaus",
"position": "Managing Director",
"startDate": "2024-10-10T00:00:00",
"endDate": null
},
{
"name": "Marc Anton Heim",
"position": "Managing Director",
"startDate": "2022-06-17T00:00:00",
"endDate": "2024-11-13T00:00:00"
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": [
"21.20.0"
]
},
"financials": [
{
"year": 2018,
"currency": "EUR",
"capital": 750000,
"capitalIsEstimate": false,
"balanceTotal": 54214941.26,
"balanceTotalIsEstimate": true,
"earnings": 2214388.46,
"earningsIsEstimate": true,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 60000000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": 3.6906474333333334,
"returnOnSalesIsEstimate": true,
"equity": 11989331.33,
"equityIsEstimate": true,
"equityRatio": 22.114441243240407,
"equityRatioIsEstimate": true,
"cash": 0,
"cashIsEstimate": true,
"receivables": 1609077.8,
"receivablesIsEstimate": true,
"liabilities": 35469528.34,
"liabilitiesIsEstimate": true
},
{
"year": 2019,
"currency": "EUR",
"capital": 750000,
"capitalIsEstimate": false,
"balanceTotal": 60787520.02,
"balanceTotalIsEstimate": false,
"earnings": 2149337.13,
"earningsIsEstimate": false,
"earningsCagr": -2.937665688521518,
"earningsCagrIsEstimate": true,
"revenue": 95913922.03,
"revenueIsEstimate": false,
"revenueCagr": 59.85653671666667,
"revenueCagrIsEstimate": true,
"returnOnSales": 2.240902138615215,
"returnOnSalesIsEstimate": false,
"equity": 14138668.46,
"equityIsEstimate": false,
"equityRatio": 23.259163156102055,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 30028497.25,
"receivablesIsEstimate": false,
"liabilities": 1510221.55,
"liabilitiesIsEstimate": false
},
{
"year": 2020,
"currency": "EUR",
"capital": 750000,
"capitalIsEstimate": false,
"balanceTotal": 50124620.34,
"balanceTotalIsEstimate": false,
"earnings": 1693084.58,
"earningsIsEstimate": false,
"earningsCagr": -12.559542262980262,
"earningsCagrIsEstimate": true,
"revenue": 97775432.99,
"revenueIsEstimate": false,
"revenueCagr": 27.655417034818107,
"revenueCagrIsEstimate": true,
"returnOnSales": 1.731605300252836,
"returnOnSalesIsEstimate": false,
"equity": 15831753.04,
"equityIsEstimate": false,
"equityRatio": 31.584783949707212,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 22169292.13,
"receivablesIsEstimate": false,
"liabilities": 2024211.08,
"liabilitiesIsEstimate": false
},
{
"year": 2021,
"currency": "EUR",
"capital": 750000,
"capitalIsEstimate": false,
"balanceTotal": 79624152.55,
"balanceTotalIsEstimate": false,
"earnings": 3582375.71,
"earningsIsEstimate": false,
"earningsCagr": 17.39216370068806,
"earningsCagrIsEstimate": true,
"revenue": 128922582.03,
"revenueIsEstimate": false,
"revenueCagr": 29.04046364993995,
"revenueCagrIsEstimate": true,
"returnOnSales": 2.7787030430141315,
"returnOnSalesIsEstimate": false,
"equity": 19414128.75,
"equityIsEstimate": false,
"equityRatio": 24.38221083459431,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 43414663.42,
"receivablesIsEstimate": false,
"liabilities": 2506873.31,
"liabilitiesIsEstimate": false
},
{
"year": 2022,
"currency": "EUR",
"capital": 750000,
"capitalIsEstimate": false,
"balanceTotal": 73068065.2,
"balanceTotalIsEstimate": false,
"earnings": 3017520,
"earningsIsEstimate": false,
"earningsCagr": 8.043610085695718,
"earningsCagrIsEstimate": true,
"revenue": 135244656.9,
"revenueIsEstimate": false,
"revenueCagr": 22.529938780064484,
"revenueCagrIsEstimate": true,
"returnOnSales": 2.231156534510015,
"returnOnSalesIsEstimate": false,
"equity": 22431648.75,
"equityIsEstimate": false,
"equityRatio": 30.699661594433458,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 36659124.46,
"receivablesIsEstimate": false,
"liabilities": 2193630.4,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 750000,
"capitalIsEstimate": false,
"balanceTotal": 48128230.39,
"balanceTotalIsEstimate": false,
"earnings": 3297906.05,
"earningsIsEstimate": false,
"earningsCagr": 11.29699395621213,
"earningsCagrIsEstimate": false,
"revenue": 133716953.32,
"revenueIsEstimate": false,
"revenueCagr": 8.661627548967509,
"revenueCagrIsEstimate": false,
"returnOnSales": 2.4663335262416073,
"returnOnSalesIsEstimate": false,
"equity": 25729554.8,
"equityIsEstimate": false,
"equityRatio": 53.46042144393084,
"equityRatioIsEstimate": false,
"cash": 752008.8,
"cashIsEstimate": false,
"receivables": 10503864.32,
"receivablesIsEstimate": false,
"liabilities": 2280825,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 750000,
"capitalIsEstimate": false,
"balanceTotal": 51943573.61,
"balanceTotalIsEstimate": false,
"earnings": 3495028.42,
"earningsIsEstimate": false,
"earningsCagr": 19.865172386585115,
"earningsCagrIsEstimate": false,
"revenue": 156240827.91,
"revenueIsEstimate": false,
"revenueCagr": 12.432326126525739,
"revenueCagrIsEstimate": false,
"returnOnSales": 2.2369495008137403,
"returnOnSalesIsEstimate": false,
"equity": 29224583.22,
"equityIsEstimate": false,
"equityRatio": 56.262172948327496,
"equityRatioIsEstimate": false,
"cash": 658699.81,
"cashIsEstimate": false,
"receivables": 15418373.32,
"receivablesIsEstimate": false,
"liabilities": 2726860.66,
"liabilitiesIsEstimate": false
}
]
}